Molecular docking studies on analogues of quercetin with d-alanine:d-alanine ligase of Helicobacter pylori

Medicinal Chemistry Research

Volumn 22, Issue 5, 2013, Pages 2139-2150

  Singh, Salam Pradeep ^a   Konwarh, Rocktotpal ^a   Konwar, Bolin Kumar ^a   Karak, Niranjan ^a  

^a TEZPUR UNIVERSITY   (India)

Author keywords

Antibacterial activity; Antimicrobial agent; Flavonoids; Molecular docking

Indexed keywords

DEXTRO ALANINE DEXTRO ALANINE LIGASE; QUERCETIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SCREENING; GASTRITIS; HELICOBACTER PYLORI; MOLECULAR DOCKING; PEPTIC ULCER; STOMACH CANCER;

EID: 84879687747     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0207-7     Document Type: Article

References (29)

1. Abdel-Monem MH, Magdy EA, Nour YA, Harfoush RA, Ibreak A (2011) Detection of Helicobacter pylori in adenotonsillar tissue of children with chronic adenotonsillitis using rapid urease test, PCR and blood serology: a prospective study. Int J Pediatr Otorhinolaryngol 75(4):568-572
2. ACD/I-Lab, Version 2.0, Advanced Chemistry Development, Inc., Toronto
3. Bolton E, Wang Y, Thiessen PA, Bryant SH (2008) PubChem: Integrated platform of small molecules and biological activities. Chapter 12 in Annual Reports in Computational Chemistry, vol 4. American Chemical Society, Washington, DC, April 2008
4. Burkert U, Allinger NL (1982) Molecular Mechanics, ACS Monograph 177. American Chemical Society, Washington, DC
5. ChemOffice 2010, CambridgeSoft Corporation, 875 Massachusetts Ave., Cambridge, MA 02139, USA
6. Cushnie TPT, Lamb AJ (2011) Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents. doi: 10.1016/j.ijantimicag.2011.02.014
7. DiMasi JA (1995) Success rates for new drugs entering clinical testing in the United States. Clin Pharmacol Ther 58:1-14
8. Ellsworth BA, Tom NJ, Bartlett PA (1996) Synthesis and evaluation of inhibitors of bacterial d-alanine:d-alanine ligases. Chem Biol 3:37-44
9. Freitas MP (2006) MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners. Org Biomol Chem 4:1154-1159
10. Hasni SA, Ippolito A, Illei G (2011) Helicobacter Pylori and autoimmune diseases. Oral Dis. doi: 10.1111/j.1601-0825.2011.01796.x
11. Ji H-F, Li X-J, Zhang H-Y (2009) Natural products and drug discovery. EMBO Rep 10(3):194-200
12. Kennedy T (1997) Managing the discovery/development interface. Drug Discov Today 2:436-444
13. Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:35-249
14. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 23:3-25
15. Liu S, Chang JS, Herberg JT, Horng MM, Tomich PK, Lin AH et al (2006) Allosteric inhibition of Staphylococcus aureus d-alanine:d-alanine ligase revealed by crystallographic studies. Proc Natl Acad Sci USA 103:15178-15183
16. Molegro APS: MVD 3.2 Molegro Virtual Docker, DK-8000 Aarhus C, Denmark
17. Mirzoeva OK, Grishanin RN, Calder PC (1997) Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential and motility of bacteria. Microbiol Res 152:239-246
18. Morris GM, Lim-Wilby M (2008) Molecular docking, methods in molecular biology. In: Kukol A (ed) Molecular modeling of proteins. Humana Press, Totowa, pp 365-382
19. Murakami A, Ashida H, Terao J (2008) Multitargeted cancer prevention by quercetin. Cancer Lett 269:315-325
20. Neuhaus FC, Hammes WP (1982) Inhibition of cell wall biosynthesis by analogues and alanine. Pharmacol Ther 14:265-319
21. Ohemeng KA, Schwender CF, Fu KP, Barrett JF (1993) DNA gyrase inhibitory and antibacterial activity of some flavones. Bioorg Med Chem Lett 3:225-230
22. Polyzos SA, Kountouras J, Zavos C, Deretzi G (2011) The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 16(2):79-88
23. Sood SK (2006) Nobel prize in physiology or medicine 2005. Indian J Physiol Pharmacol 50(1):91-92
24. Thomsen R, Christensen M (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49(11):3315-3321
25. Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, Wang J, Xiao J, Zhang J, Bryant SH (2010) An overview of the PubChem BioAssay resource. Nucleic Acids Res 38:D255-D266
26. Wu D, Kong Y, Han C, Chen J, Hu L, Jiang H, Shen X (2008a) d-Alanine:d-alanine ligase as a new target for the flavonoids quercetin and apigenin. Int J Antimicrob Agents 32:421-426
27. Wu D, Zhang L, Kong Y, Du J, Chen S, Chen J, Ding J, Jiang H, Shen X (2008b) Enzymatic characterization and crystal structure analysis of the d-alanine:d-alanine ligase from Helicobacter pylori. Proteins 72(4):1148-1160
28. Yadava U, Gupta H, Roychoudhury M (2011) A comparison of crystallographic and DFT optimized geometries on two taxane diterpenoids and docking studies with phospholipase A2. Med Chem Res. doi: 10.1007/s00044-011-9724-z
29. Zavos C, Kountouras J, Katsinelos P, Polyzos SA, Deretzi G, Zavos N, Fragaki M, Diamantidis MD (2011) Modern industrialisation may increase primary open-angle glaucoma prevalence through easier transmission of Helicobacter pylori infection. Med Hypotheses 76(5):766-767